Evidence map›Paper›PMID 31399543›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Second harmonic generation detection of Ras conformational changes and discovery of a small molecule binder.

Elizabeth Donohue, Sina Khorsand, Gabriel Mercado, Kristen M Varney, Paul T Wilder, Wenbo Yu, Alexander D MacKerell, Patrick Alexander, Que N Van, Ben Moree and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Analytical challenges of glycosaminoglycans at biological interfaces.Analytical and bioanalytical chemistry · 2022
    Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Elizabeth DonohueHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158.
Sina KhorsandHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158.
Gabriel MercadoBiodesy, Inc., South San Francisco, CA 94080.
Kristen M VarneyCenter for Biomolecular Therapeutics, School of Medicine, University of Maryland, Baltimore, MD 21201.
Paul T WilderCenter for Biomolecular Therapeutics, School of Medicine, University of Maryland, Baltimore, MD 21201.
Wenbo YuCenter for Biomolecular Therapeutics, School of Medicine, University of Maryland, Baltimore, MD 21201.
Alexander D MacKerellCenter for Biomolecular Therapeutics, School of Medicine, University of Maryland, Baltimore, MD 21201.
Patrick AlexanderNational Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702.
Que N VanNational Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702.
Ben MoreeBiodesy, Inc., South San Francisco, CA 94080.ORCID 0000-0002-8811-7400
Andrew G StephenNational Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702.
David J WeberCenter for Biomolecular Therapeutics, School of Medicine, University of Maryland, Baltimore, MD 21201.ORCID 0000-0002-8824-1110
Joshua SalafskyDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158 frank.mccormick@ucsf.edu joshua.salafsky@ucsf.edu.
Frank McCormickHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158; frank.mccormick@ucsf.edu joshua.salafsky@ucsf.edu.
University of Maryland, Baltimore · USLeidos (United States) · USUniversity of California, San Francisco · US

Funding

Molecular and Cellular Mechanisms in CancerT32CA108462 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI · 2004 to 2024
$10.4M
New Ways of Targeting K-RasR35CA197709 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCORMICK, FRANK PATRICK · 2016 to 2022
$6.7M
Biodesy Delta System for San Francisco Bay Area RegionS10OD023482 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCORMICK, FRANK PATRICK · 2017 to 2017
$600k
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCI NIH HHS R35 CA197709NCI NIH HHS T32 CA108462NIH HHS S10 OD023482
6 · The paper itself

Abstract

Second harmonic generation (SHG) is an emergent biophysical method that sensitively measures real-time conformational change of biomolecules in the presence of biological ligands and small molecules. This study describes the successful implementation of SHG as a primary screening platform to identify fragment ligands to oncogenic Kirsten rat sarcoma (KRas). KRas is the most frequently mutated driver of pancreatic, colon, and lung cancers; however, there are few well-characterized small molecule ligands due to a lack of deep binding pockets. Using SHG, we identified a fragment binder to KRas

Indexed as

Amino Acid SubstitutionBinding SitesHumansMutation, MissenseNuclear Magnetic Resonance, BiomolecularProtein Kinase InhibitorsProto-Oncogene Proteins p21(ras)KRAS protein, humanProtein Kinase InhibitorsProto-Oncogene Proteins p21(ras)cancerKRASsecond harmonic generationsmall G proteinsmall molecule inhibitors

Identifiers

PMID31399543
PMCPMC6717309
OpenAlexW2968665721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.